Lupus and Vascular Disease: Updates From ACR 2018

Recent studies explore the vascular underpinnings of neuropsychiatric damage as well as the risk of resistant hypertension in patients with SLE.

References1. Mikdashi JA. Determinants of Major Neurocognitive Disorder (Vascular Dementia) in SLE: The Importance of Treatment Adherence of SLE Disease Activity and Cardiovascular Risk Factors [abstract]. Arthritis Rheumatol. 2018;70(suppl 10). Abstract 754. Accessed October 21, 2018.2. Gandelman JS, Khan OA, Shuey M, et al. Increased Incidence and Prevalence of Resistant Hypertension in Patients with Systemic Lupus Erythematosus: A Retrospective Cohort Study [abstract]. Arthritis Rheumatol. 2018;70(suppl 10). Abstract 706. Accessed October 21, 2018.This information is brought to you by Rheumatology Network and is not sponsored by, nor a part of, the American College of Rheumatology.

Recent Videos
Arshad Khanani, MD: Four-Year Outcomes of Faricimab for DME in RHONE-X | Image Credit: Sierra Eye Associates
A panel of 5 experts on iron deficiency anemia
Dilraj Grewal, MD: Development of MNV in Eyes with Geographic Atrophy in GATHER | Image Credit: Duke Eye Center
1 KOL is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
Margaret Chang, MD: Two-Year Outcomes of the PDS for Diabetic Retinopathy | Image Credit: Retina Consultants Medical Group
Phase 2 Data Shows KP1077 Meaningfully Improves Idiopathic Hypersomnia Symptoms
Carl C. Awh, MD: | Image Credit:
Raj K. Maturi, MD: 4D-150 for nAMD in PRISM Population Extension Cohort | Image Credit: Retina Partners Midwest
© 2024 MJH Life Sciences

All rights reserved.